# FundRx

FundRx is an Asset Manager based in Nashville, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Nashville, United States
- **Region:** North America
- **Address:** Nashville, TN, United States
- **Assets under management:** Undisclosed
- **Website:** fundrx.com
- **LinkedIn:** https://www.linkedin.com/company/fundrx

## Regulatory record

- **Reports private funds:** No

## About

FundRx is a venture capital firm that invests in biotech and healthcare sectors. It provides funding to startups addressing health issues. FundRx was founded in 2015 and is based in New York, New York.

## Sectors

- Digital Health
- Healthcare Services

## Questions

### Who runs investment decisions at FundRx?

FundRx does not publicly disclose a named CIO or managing partner list. Based on public record, the firm operates through a network of physician venture partners who source and diligence deals, with final investment decisions made by a central partnership group in Nashville. Specific names and titles have not been confirmed through the firm's own communications.

### How does FundRx source proprietary deal flow?

FundRx sources deals through a network of practicing clinicians who act as scouts and venture partners. These physicians encounter early-stage healthcare companies through their own clinical practice — seeing products, devices, or software workflows before they reach pitch decks or accelerators. This embedded-sourcing model gives the firm access to companies that often have not formally fundraised.

### Does FundRx participate in fund commitments or only direct deals?

FundRx is structured for direct pre-seed and seed equity investments, not as a fund-of-funds. There is no public record of the firm making LP commitments into other venture funds. Its model is to write first checks directly into operating companies, then syndicate with domain-expert angels and specialist healthcare funds on follow-on rounds.

### What investment stages does FundRx typically target?

The firm targets pre-seed and seed-stage companies. FundRx's thesis is to invest at the earliest institutional entry point — often before a startup has revenue, a full team, or regulatory clearance — and reserve capital for follow-on participation through later seed rounds. The firm does not publicly lead growth-stage or late-stage rounds.

### Which sectors does FundRx explicitly avoid?

FundRx has not published an explicit exclusion list. Based on its investment activity, the firm does not invest in non-healthcare sectors such as enterprise SaaS, fintech, or consumer internet. Within healthcare, there is no public indication that the firm avoids regulated medical devices or diagnostics, but payer-facing or pharma-services deals have not been prominently featured in its known portfolio.

## Related profiles

- [FGF Management](https://altss.com/profile/fgf-management)
- [FS Investments](https://altss.com/profile/fs-investments)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/fundrx

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology